An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer

Global burden and trends in premenopausal and postmenopausal breast cancer: a population-based study

(2020) Emily Heer et al.   Lancet Global Health

Impact of Cumulative Chemotherapy Dose on Survival With Adjuvant FEC-D Chemotherapy for Breast Cancer

(2019) Zachary Veitch et al.   Journal of the National Comprehensive Cancer Network

1816PProphylaxis with lipegfilgrastim in patients with primary breast cancer receiving dose dense chemotherapy: Results from the German NIS NADENS

(2019) M Kiechle et al.   ANNALS OF ONCOLOGY

1697PUse of lipegfilgrastim for the prophylaxis of chemotherapy-induced neutropenia: Pan-European non-interventional study

(2018) G Steger et al.   ANNALS OF ONCOLOGY

Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia

(2015) Louis Pelus et al.   International Journal of Nanomedicine

Effectiveness of an Adjuvant Chemotherapy Regimen for Early-Stage Breast Cancer

(2015) Takeo Fujii et al.   JAMA Oncology

Efficacy, effectiveness and safety of long-acting granulocyte colony-stimulating factors for prophylaxis of chemotherapy-induced neutropenia in patients with cancer: a systematic review

(2014) Alena M. Pfeil et al.   SUPPORTIVE CARE IN CANCER

Efficacy and safety of lipegfilgrastim versus pegfilgrastim: a randomized, multicenter, active-control phase 3 trial in patients with breast cancer receiving doxorubicin/docetaxel chemotherapy

(2013) Igor Bondarenko et al.   BMC CANCER

Trends in breast cancer incidence and mortality in the United States: implications for prevention

(2013) Adetunji T. Toriola et al.   BREAST CANCER RESEARCH AND TREATMENT

Trastuzumab-Related Cardiotoxicity Following Anthracycline-Based Adjuvant Chemotherapy: How Worried Should We Be?

(2010) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY

Prophylaxis of chemotherapy-induced febrile neutropenia with granulocyte colony-stimulating factors: where are we now?

(2010) Matti Aapro et al.   SUPPORTIVE CARE IN CANCER

Issues in Outcomes Research: An Overview of Randomization Techniques for Clinical Trials

(2009) Minsoo Kang et al.   JOURNAL OF ATHLETIC TRAINING

Dose-Dense Adjuvant Doxorubicin and Cyclophosphamide Is Not Associated With Frequent Short-Term Changes in Left Ventricular Ejection Fraction

(2009) Patrick G. Morris et al.   JOURNAL OF CLINICAL ONCOLOGY